Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel A Avilion

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|November 13, 2009
Whole-mount assays for gene induction and barrier formation in the developing epidermisCarolyn Byrne, Ariel A Avilion, Ryan F O'Shaughnessy, et al.
Genes & Development|January 7, 2003
Multipotent cell lineages in early mouse development depend on SOX2 functionAriel A Avilion, Silvia K Nicolis, Larysa H Pevny, et al.
Molecular and Cellular Biology|January 20, 2005
Desmosomal cadherin misexpression alters beta-catenin stability and epidermal differentiationMatthew J Hardman, Ke Liu, Ariel A Avilion, et al.
The Journal of Biological Chemistry|April 19, 2007
AKT-dependent HspB1 (Hsp27) activity in epidermal differentiationRyan F L O'Shaughnessy, Jonathan C Welti, James C Cooke, et al.
The Journal of Investigative Dermatology|April 28, 2005
Late cornified envelope family in differentiating epithelia--response to calcium and ultraviolet irradiationBenjamin Jackson, Claudia M L J Tilli, Matthew J Hardman, et al.
The Journal of Investigative Dermatology|April 6, 2007
Rodent Lce gene clusters; new nomenclature, gene organization, and divergence of human and rodent genesStuart J Brown, Claudia M L J Tilli, Ben Jackson, et al.
Journal of Cell Science|April 23, 2011
TALE homeodomain proteins regulate site-specific terminal differentiation, LCE genes and epidermal barrierBen Jackson, Stuart J Brown, Ariel A Avilion, et al.
Leukemia|April 23, 2020
Phase 1 study of the anti-BCMA antibody-drug conjugate AMG 224 in patients with relapsed/refractory multiple myelomaHans C Lee, Noopur S Raje, Ola Landgren, et al.
Leukemia & Lymphoma|May 3, 2022
Open-label, phase 2 study of blinatumomab after frontline R-chemotherapy in adults with newly diagnosed, high-risk DLBCLDeborah A Katz, Joan D Morris, Michael P Chu, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|November 13, 2009
Whole-mount assays for gene induction and barrier formation in the developing epidermisCarolyn Byrne, Ariel A Avilion, Ryan F O'Shaughnessy, et al.
Genes & Development|January 7, 2003
Multipotent cell lineages in early mouse development depend on SOX2 functionAriel A Avilion, Silvia K Nicolis, Larysa H Pevny, et al.
Molecular and Cellular Biology|January 20, 2005
Desmosomal cadherin misexpression alters beta-catenin stability and epidermal differentiationMatthew J Hardman, Ke Liu, Ariel A Avilion, et al.
The Journal of Biological Chemistry|April 19, 2007
AKT-dependent HspB1 (Hsp27) activity in epidermal differentiationRyan F L O'Shaughnessy, Jonathan C Welti, James C Cooke, et al.
The Journal of Investigative Dermatology|April 28, 2005
Late cornified envelope family in differentiating epithelia--response to calcium and ultraviolet irradiationBenjamin Jackson, Claudia M L J Tilli, Matthew J Hardman, et al.
The Journal of Investigative Dermatology|April 6, 2007
Rodent Lce gene clusters; new nomenclature, gene organization, and divergence of human and rodent genesStuart J Brown, Claudia M L J Tilli, Ben Jackson, et al.
Journal of Cell Science|April 23, 2011
TALE homeodomain proteins regulate site-specific terminal differentiation, LCE genes and epidermal barrierBen Jackson, Stuart J Brown, Ariel A Avilion, et al.
Leukemia|April 23, 2020
Phase 1 study of the anti-BCMA antibody-drug conjugate AMG 224 in patients with relapsed/refractory multiple myelomaHans C Lee, Noopur S Raje, Ola Landgren, et al.
Leukemia & Lymphoma|May 3, 2022
Open-label, phase 2 study of blinatumomab after frontline R-chemotherapy in adults with newly diagnosed, high-risk DLBCLDeborah A Katz, Joan D Morris, Michael P Chu, et al.
Pageof 1